series-b
Stage
1
Investors
About
Audion Therapeutics is a clinical-stage biotechnology company developing small-molecule gamma-secretase inhibitors administered intratympanically to treat acquired sensorineural hearing loss by restoring cochlear hair cell function.
Explore Audion Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.